A REVIEW ON NANOTIZED HERBAL DRUGSAbstract
A budding interest in Nanopharmaceuticals had generated a number of advancements throughout recent years with a focus on engineering novel applications. Nanophytomedicines are prepared from active phytoconstituents or standardized extracts. The world market for nanomedicine is estimated to reach $130.9 billion by the fiscal year 2016. Liposome nanoparticle (NP) with entrapped doxorubicin was reported by researchers to be 300 times more effective because of better pharmacokinetic ability in treatment of Kaposi sarcoma. Nanotized herbal drug containing active principles of seawort, cassia twig and liquorice root was found to be effective in pulmonary, liver, bone and skin cancer. Nanotechnology also offers the ability to detect diseases at much earlier stages, such as finding hidden or overt metastatic colonies often seen in patients diagnosed with breast, lung, colon, prostate, and ovarian cancer. However, the safety and long-term effects of nanoformulations must not be overlooked. This review will provide a brief discussion of the major nanopharmaceutical formulations as well as the impact of nanotechnology on herbal drugs in future.
Anupam Kumar Sachan* and Ankita Gupta
Dayanand Dinanath College, Institute of Pharmacy, Kanpur, Uttar Pradesh, India
24 June, 2014
12 October, 2014
16 November, 2014
01 March, 2015